Stifel Nicolaus Cuts Amdocs (NASDAQ:DOX) Price Target to $88.00

Amdocs (NASDAQ:DOX) had its price target lowered by Stifel Nicolaus from $97.00 to $88.00 in a research note published on Wednesday, MarketBeat.com reports. Stifel Nicolaus currently has a buy rating on the technology company’s stock.

A number of other equities research analysts have also weighed in on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Barclays decreased their price objective on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a report on Wednesday. Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Bank of America lowered their price target on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Finally, Wall Street Zen cut Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, January 3rd. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $92.33.

Amdocs Price Performance

DOX stock opened at $73.34 on Wednesday. Amdocs has a one year low of $70.24 and a one year high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.17. The stock has a market cap of $7.92 billion, a PE ratio of 14.19, a P/E/G ratio of 1.26 and a beta of 0.40. The firm has a 50 day simple moving average of $80.15 and a two-hundred day simple moving average of $82.39.

Amdocs (NASDAQ:DOX) last released its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The business had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter last year, the business posted $1.66 earnings per share. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, analysts predict that Amdocs will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be paid a $0.569 dividend. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date is Tuesday, March 31st. This represents a $2.28 annualized dividend and a dividend yield of 3.1%. Amdocs’s dividend payout ratio (DPR) is currently 40.81%.

Hedge Funds Weigh In On Amdocs

A number of institutional investors have recently bought and sold shares of the stock. Pzena Investment Management LLC raised its stake in shares of Amdocs by 82.6% in the fourth quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock worth $969,100,000 after buying an additional 5,443,766 shares during the period. LSV Asset Management lifted its stake in Amdocs by 0.8% in the 4th quarter. LSV Asset Management now owns 3,678,532 shares of the technology company’s stock worth $296,159,000 after purchasing an additional 29,829 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of Amdocs by 1.8% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock worth $253,786,000 after buying an additional 54,676 shares in the last quarter. Wellington Management Group LLP raised its holdings in shares of Amdocs by 3.0% during the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock worth $258,583,000 after acquiring an additional 91,900 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in Amdocs by 0.3% during the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock valued at $251,602,000 after purchasing an additional 9,207 shares in the last quarter. 92.02% of the stock is owned by institutional investors.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.